Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosis
暂无分享,去创建一个
Y. Tada | Y. Asano | M. Sugaya | T. Kadono | S. Sato | H. Fujita | T. Miyagaki | H. Suga | H. Ohmatsu
[1] M. Meurer,et al. Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma. , 2011, The American journal of pathology.
[2] Wolfram Sterry,et al. Pathogenesis of Mycosis fungoides , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[3] K. Hon,et al. Exploring CCL18, eczema severity and atopy , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[4] M. Ewen,et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.
[5] Wei Zhang,et al. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified , 2011, Leukemia & lymphoma.
[6] Shinichi Sato,et al. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. , 2010, The Journal of investigative dermatology.
[7] N. Yawalkar,et al. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. , 2010, Journal of the American Academy of Dermatology.
[8] C. Lam,et al. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. , 2010, International immunology.
[9] Steven J. M. Jones,et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.
[10] Min‐Geol Lee,et al. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy , 2010, Experimental dermatology.
[11] C. Günther,et al. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course , 2009, The British journal of dermatology.
[12] M. Netea,et al. Enhanced interleukin‐10 production by dendritic cells upon stimulation with Toll‐like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion , 2009, Scandinavian journal of rheumatology.
[13] H. Nilsson‐Ehle,et al. Expression of CD68+ tumor‐associated macrophages in patients with diffuse large B‐cell lymphoma and its relation to prognosis , 2008, Pathology international.
[14] J. H. Lee,et al. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients , 2007, Experimental dermatology.
[15] T. Kuzel,et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Carucci,et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. , 2007, The Journal of allergy and clinical immunology.
[17] A. Blauvelt,et al. Oncostatin M Enhances CCL21 Expression by Microvascular Endothelial Cells and Increases the Efficiency of Dendritic Cell Trafficking to Lymph Nodes1 , 2006, The Journal of Immunology.
[18] T. Kuzel,et al. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides. , 2006, Journal of the American Academy of Dermatology.
[19] M. Sugaya,et al. Elevated serum CTACK/CCL27 levels in CTCL. , 2006, The Journal of investigative dermatology.
[20] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[21] J. Van Damme,et al. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes , 2005, Journal of leukocyte biology.
[22] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[23] L. Showe,et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. , 2005, The Journal of clinical investigation.
[24] T. Biedermann,et al. CCL18 Is Expressed in Atopic Dermatitis and Mediates Skin Homing of Human Memory T Cells , 2005, The Journal of Immunology.
[25] W. Fridman,et al. CC Chemokine Ligand 18, An Atopic Dermatitis-Associated and Dendritic Cell-Derived Chemokine, Is Regulated by Staphylococcal Products and Allergen Exposure1 , 2004, The Journal of Immunology.
[26] H. Takamori,et al. Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[27] J. Travers,et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.
[28] G. Goteri,et al. Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides , 2003, Journal of clinical pathology.
[29] A. Mantovani,et al. Unique Regulation of CCL18 Production by Maturing Dendritic Cells1 , 2003, The Journal of Immunology.
[30] E. Papadavid,et al. The relevance of peripheral blood T‐helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome , 2003, The British journal of dermatology.
[31] K. Matsushima,et al. High level of thymus and activation‐regulated chemokine in blister fluid and sera of patients with bullous pemphigoid , 2003, The British journal of dermatology.
[32] M. Dhodapkar,et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. , 2002, Blood.
[33] P. Puddu,et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. , 2002, European journal of dermatology : EJD.
[34] Y. Shimada,et al. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis , 2001, Archives of Dermatological Research.
[35] C. Figdor,et al. The Dendritic Cell-Specific CC-Chemokine DC-CK1 Is Expressed by Germinal Center Dendritic Cells and Attracts CD38-Negative Mantle Zone B Lymphocytes , 2001, The Journal of Immunology.
[36] Koichiro Nakamura,et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. , 2001, The Journal of allergy and clinical immunology.
[37] E. Bröcker,et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. , 2001, The American journal of pathology.
[38] B. Antus,et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.
[39] Antonio Lanzavecchia,et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.
[40] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[41] Y. Sakaki,et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.
[42] T. Mcclanahan,et al. A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.
[43] M. Peitsch,et al. The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases , 1997, Journal of leukocyte biology.
[44] A. Rook,et al. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. , 1992, The Journal of investigative dermatology.
[45] R. Martí,et al. Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. , 1991, Archives of dermatology.
[46] P. Bunn,et al. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. , 1990, Journal of the National Cancer Institute.
[47] R. Jordon,et al. Bullous pemphigoid: a cause of peripheral blood eosinophilia. , 1983, Journal of the American Academy of Dermatology.
[48] M. G. Lewis,et al. Target Role of Langerhans Cells in Mycosis Fungoides: Transmission and Immuno‐Electron Microscopic Studies , 1979, Journal of cutaneous pathology.
[49] Koichiro Nakamura,et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. , 2003, Journal of the American Academy of Dermatology.
[50] G. Burg,et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. , 2002, Journal of the American Academy of Dermatology.
[51] E. Vonderheid,et al. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. , 1996, Archives of dermatology.
[52] R. Winkelmann,et al. Atopic dermatitis and Sézary syndrome. , 1984, Archives of dermatology.